Be Ready for a New Omalizumab (Xolair) Indication
May 2024
Omalizumab (Xolair) may pop up on more home med lists.
We’re used to seeing omalizumab used for indications such as allergic asthma.
Now it’s the first monoclonal antibody approved for food allergies.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote